Chronic Cutaneous Lupus Erythematosus: Thalidomide Treatment of 11 Patients

Archives of Dermatology

Volumn 119, Issue 10, 1983, Pages 812-815

  Hasper, Marja F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; THALIDOMIDE;

ADVERSE DRUG REACTION; CLINICAL ARTICLE; CONJUNCTIVITIS; DROWSINESS; DRUG THERAPY; HUMAN; INTOXICATION; MACULAR SKIN LESION; NERVOUS SYSTEM; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; SECONDARY AMENORRHEA; SKIN LUPUS ERYTHEMATOSUS; SKIN TOXICITY; THERAPY; VERTIGO; VISUAL SYSTEM; WEIGHT GAIN;

ADULT; AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGE; RECURRENCE; THALIDOMIDE;

EID: 0020544628     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1983.01650340022013     Document Type: Article

References (25)

1. Sheskin J: The treatment of lepra reaction in lepromatous leprosy: Fifteen years' experience with thalidomide. Int J Dermatol 1980;19:318–322.
2. Barba Rubio J, Franco González F: Lupus eritematoso discoide y talidomida. Dermatol Rev Mex 1975;19:131–139.
3. Sontheimer RD, Thomas JR, Gilliam JN: Subacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979;115:1409–1415.
4. Samsoen M, Grosshans E, Basset A: La thalidomide dans le traitement du lupus érythémateux chronique (LEC). Ann Dermatol Venereol 1980;107:515–522.
5. Knop J, Happle R, Bonsmann G, et al: Treatment of chronic discoid lupus erythematosus with thalidomide. Arch Dermatol Res 1981;271:165–170.
6. Hasper MF, Klokke AH: Thalidomide in the treatment of chronic discoid lupus erythematosus. Acta Derm Venereol 1982;62:321–324.
7. Levy L, Fasal P, Levan NE, et al: Treatment of erythema nodosum leprosum with thalidomide. Lancet 1973;2:324–325.
8. Eravelly J, Waters MFR: Thalidomide in Weber-Christian disease. Lancet 1977;1:251.
9. Calnan CD, Meara RH: Actinic prurigo (Hutchinson's summer prurigo). Clin Exp Dermatol 1977;2:365–372.
10. Londono F: Thalidomide in the treatment of actinic prurigo. Int J Dermatol 1973;12:326–328.
11. Londono F: Studies of the mechanism of action of thalidomide in chronic polymorphic light eruption. Read before the Fourth World Congress of the International Society of Tropical Dermatology, New Orleans, Sept 23-27, 1979.
12. Sheskin J: Zur Therapie des Prurigo Nodularis Hyde mit Thalidomid. Hautarzt 1975;26:215–217.
13. Van den Broek H: Treatment of prurigo nodularis with thalidomide. Arch Dermatol 1980;116:571–572.
14. Mascaro JM, Lecha M, Torras H: Thalidomide in the treatment of recurrent necrotic and giant mucocutaneous aphthae and aphthosis. Arch Dermatol 1979;115:636–637.
15. Knop J, Happle R, Vakilzadeh F, et al: Treatment of lupus erythematosus profundus with thalidomide. Arch Dermatol Res 1981;270:229.
16. Gusdon JP, Cohen C: Effect of thalidomide on the antibody response. Am J Obstet Gynecol 1968;100:952–956.
17. Hellmann K, Duke DI, Tucker DF: Prolongation of skin homograft survival by thalidomide. Br Med J 1965;2:687–689.
18. Turk JL, Hellmann K, Duke DI: Effect of thalidomide on the immunological response in local lymph nodes after a skin homograft. Lancet 1966;1:1134–1136.
19. Klüken N, Ventz W: Indications for thalidomide therapy for leprosy. Int J Dermatol 1974;13:20–25.
20. Hastings RC, Morales MJ, Shannon EJ: Studies on the mechanism of action of thalidomide in leprosy. Pharmacologist 1976;18:218–221.
21. Saläun J: L'action tératogène de la thalidomide. Ann Biol Clin 1968;7:307–326.
22. Roath S, Elves MW, Israels MCG: Effects of thalidomide and its derivates on human leucocytes cultured in vitro. Lancet 1963;1:249–250.
23. Faure M, Thivolet J, Gaucherand M: Inhibition of PMN leucocytes chemotaxis by thalidomide. Arch Dermatol Res 1980;269:275–280.
24. Lutwak-Mann C: Observations on progeny of thalidomide-treated male rabbits. Br Med J 1964;1:1090–1091.
25. Lutwak-Mann C, Schmid K, Keberle H: Thalidomide in rabbit semen. Nature 1967;214:1018–1020.